7 Sept 2015
Clariant to show pharmaceutical market multifaceted product offering at CPhI Worldwide 2015
- Broad portfolio backed by strong support for the pharmaceutical industry on display in Hall 7, Booth 7F28
- Packaging and device materials, color and additives, pretested and compliant
- Controlled atmosphere packaging for protection against moisture and oxygen
- Specialty polymers and active ingredients for healthcare applications
Muttenz, September 7, 2015 – Clariant, a world leader in specialty chemicals, will be at CPhI Worldwide 2015 to demonstrate how its commitment to collaborating closely with customers can deliver effective and efficient innovations in several different segments of the pharmaceutical and healthcare market. The annual CPhI Worldwide exhibition this year takes place in Madrid on October 13 - 15.
Three Clariant business groups will exhibit together in Hall 7, Stand 7F28.
- Business Unit Industrial & Consumer Specialties will present innovative, sustainable and trend-based products to support the changing needs of the pharmaceutical market. High-purity ingredients include Polyglykol universally applicable pharmaceutical polymers, and a complete range of Macrogols with various molecular weights, all of them supported by CEP certification and DMF.
- Clariant Healthcare Packaging manufactures controlled atmosphere-packaging that helps to protect healthcare products from humidity and oxygen. Its broad portfolio includes industry-leading desiccant canisters and packets; tubes and desiccant stoppers; Tubairless®1, an innovative airless packaging system for protecting and dispensing sensitive pharmaceutical semi-solids and creams; EQ-Can® and EQ-Pak® humidity regulators; and more.
- Clariant Healthcare Polymer Solutions will featuring the MEVOPUR® and the REMAFIN®-EP brands of color and performance masterbatches and compounds developed specifically for the medical device and pharmaceutical packaging sector, including new UV-blocking protection for transparent packaging, improved resistance to e-beam, gamma, X-ray sterilization, and new anti-static and anti-blocking functionality for pharmaceutical packaging films. The REMAFIN-EP range of white masterbatches for pharmaceutical packaging has been extended with increased regulatory support with test documentation for USP661.
By understanding customer needs and expectations, Clariant is able to offer comprehensive and viable solutions that increase efficiency, reduce costs and improve the environmental compatibility of products.
For more information, visit Clariant at CPhI Hall 7, Stand 7F28.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
®1 = TRADEMARK OF PUMPART SYSTEM
EQ-Can®, EQ-Pak®, MEVOPUR® AND REMAFIN® ARE TRADEMARKS OF CLARIANT REGISTERED IN MANY COUNTRIES.
Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2014 the company employed a total workforce of 17 003. In the financial year 2014, Clariant recorded sales of CHF 6.116 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: increase profitability, reposition portfolio, add value with sustainability, foster innovation and R&D, and intensify growth.
Related documents
Clariant to show pharmaceutical market multifaceted product offering at CPhI Worldwide 2015
Editorial enquiries
Carsten Seum
Clariant International Ltd
Stefanie Nehlsen
Clariant International Ltd
stefanie.nehlsen@clariant.com
Josina van der Velden
EMG